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Abstract. 
 
Phosphoinositide 3 kinase/Akt pathway
plays an essential role in neuronal survival. However,
the cellular mechanisms by which Akt suppresses cell
death and protects neurons from apoptosis remain un-
clear. We previously showed that transient expression
of constitutively active Akt inhibits ceramide-induced
death of hybrid motor neuron 1 cells. Here we show
that stable expression of either constitutively active Akt
or Bcl-2 inhibits apoptosis, but only Bcl-2 prevents the
release of cytochrome c from mitochondria, suggesting
that Akt regulates apoptosis at a postmitochondrial
level. Consistent with this, overexpressing active Akt
rescues cells from apoptosis without altering expression
levels of endogenous Bcl-2, Bcl-x, or Bax. Akt inhibits
apoptosis induced by microinjection of cytochrome c
and lysates from cells expressing active Akt inhibit cy-
tochrome c induced caspase activation in a cell-free as-
say while lysates from Bcl-2–expressing cells have no
 
effect. Addition of cytochrome c and dATP to ly-
sates from cells expressing active Akt do not activate
caspase-9 or -3 and immunoprecipitated Akt added to
control lysates blocks cytochrome c–induced activation
of the caspase cascade. Taken together, these data sug-
 
gest that Akt inhibits activation of caspase-9 and -3
by posttranslational modiﬁcation of a cytosolic factor
downstream of cytochrome c and before activation of
caspase-9.
Key words: protein serine-threonine kinase • cyto-
chrome c • apoptosis • neuron • mitochondria
 
Introduction
 
Apoptosis plays an important role in the development and
homeostasis of multicellular organisms (Vaux and Kors-
meyer, 1999). In the nervous system, apoptosis is required
for normal development (Oppenheim, 1991; Jacobson et
al., 1997) and has been implicated in the pathogenesis of
various neurodegenerative conditions, including acute in-
sults to the central nervous system such as head trauma and
spinal cord injury, and chronic degeneration such as Alzhei-
mer’s disease and Huntington’s disease (Thompson, 1995).
Genetic studies in the nematode 
 
Caenorhabditis elegans
 
have provided an understanding of apoptosis at the molec-
 
ular level that show that three genes, 
 
ced-3
 
, 
 
ced-4
 
, and
 
ced-9
 
, play critical roles in regulating the cell death pro-
 
gram. 
 
ced-3 
 
and 
 
ced-4 
 
were
 
 
 
identified as proapoptotic genes,
whereas
 
 ced-9
 
 was identified as an antiapoptotic gene
(Hengartner and Horvitz, 1994). Mammalian homologues
of CED-3 have been identified as the caspase family.
Caspases are activated in response to apoptotic stimuli and
subsequently cleave cellular proteins to cause cell death
(Salvesen and Dixit, 1997; Thornberry and Lazebnik,
1998). The mammalian homologue of CED-4 is Apaf-1
(apoptotic protease activating factor 1), which is important
for initiating a cytochrome c–dependent caspase activation
cascade (Zou et al., 1997; Slee et al., 1999). Mammalian ho-
mologues of CED-9 are members of the Bcl-2 family,
which includes both positive and negative regulators of cell
survival (Adams and Cory, 1998; Gross et al., 1999).
Recent biochemical studies have revealed that caspase
activation during apoptosis is a tightly regulated process
(Salvesen and Dixit, 1997; Thornberry and Lazebnik,
1998; Budihardjo et al., 1999). Apoptotic stimuli such as
activation of cell surface receptors or environmental stress
can induce cytochrome c release from mitochondria
(Green and Reed, 1998). Once in the cytosol, cytochrome
c binds to Apaf-1 and induces its oligomerization. Oligo-
merization of Apaf-1 recruits procaspase-9 and results in
subsequent caspase-9 activation (Srinivasula et al., 1998;
Zou et al., 1999). Active caspase-9 cleaves procaspase-3
and generates active caspase-3. Active caspase-3 cleaves a
number of important cellular proteins to execute cell
death and activate additional downstream caspases (Slee
et al., 1999). Phenotypes of caspase-3–, caspase-9–, or
Apaf-1–deficient mice are very similar to each other in
that all these mice manifest brain overgrowth due to re-
duced apoptosis during brain development (Cecconi et al.,
1998; Hakem et al., 1998; Kuida et al., 1998; Yoshida et al.,
 
1998). On the other hand, caspase-1–, caspase-2–, caspase-8–,
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caspase-11–, Bid-, or FADD-deficient mice do not show
obvious defects in brain development (Los et al., 1999; Yin
et al., 1999). These genetic studies confirm the critical
roles for Apaf-1, caspase-9, and caspase-3 in regulating
neuronal apoptosis.
Neurons are dependent on neurotrophic factors for sur-
vival, and removal of such factors results in apoptosis.
Among the growth factor signaling molecules, phospho-
inositide 3 (PI-3)
 
1
 
 kinase and mitogen-activated protein
(MAP) kinase have been shown to be important for neu-
ronal survival (Pettmann and Henderson, 1998). Recent
studies indicate that the protective effects of PI 3-kinase
are mediated primarily by one of its downstream targets—
Akt (Franke et al., 1997). Upon activation by PI 3-kinase,
Akt phosphorylates Bad at Ser136. This decreases the
binding of Bad to Bcl-xL at the mitochondrial membrane
and increases its binding to 14-3-3 in the cytosol (Zha et
al., 1996; Datta et al., 1997). It has been speculated that
Akt inhibits apoptosis by maintaining Bcl-x function and
preventing cytochrome c release from mitochondria. How-
ever, a direct effect of Akt in regulating cytochrome c
translocation during apoptosis has not been shown. More-
over, it remains to be explored whether Akt may also in-
hibit apoptosis independent of cytochrome c release.
In this report, we examine the cellular mechanism by
which Akt inhibits apoptosis in hybrid motor neuron 1
(HMN1) cells, a neuronal cell line that requires PI 3-kinase
but not MAP kinase for survival. By generating stable
HMN1 lines overexpressing constitutively active Akt, sub-
cellular fractionation, cell-free assays of apoptosis, and mi-
croinjection, we investigated the effects of Akt on several
critical apoptotic events, with particular focus on its effect
on cytochrome c redistribution. Our data indicate that Akt
inhibits apoptosis downstream of cytochrome c release
based on the following observations: (a) Akt inhibits cell
death but does not block release of cytochrome c, (b) Akt
inhibits cytochrome c–induced caspase activation in a cell
free assay, and (c) HMN1 cells expressing active Akt are
resistant to apoptosis induced by microinjection of cyto-
chrome c. In sum, our study indicates that Akt plays an im-
portant role in suppressing neural apoptosis at a postmito-
chondrial stage, downstream of cytochrome c release and
before activating caspase-9.
 
Materials and Methods
 
Materials
 
C2-ceramide, C2-dihydroceramide, PD 98059, and LY 294002 were ob-
tained from Calbiochem. LipofectAMINE was obtained from Life Tech-
nologies. Hygromycin B was from Boehringer. Fetal bovine serum was
from HyClone. Polyvinylidene difluoride transfer membrane, ECL sub-
strate, and [gamma-
 
32
 
P] ATP were from NEN Life Science Products.
pCR3.1 vector was from Invitrogen. Caspase-9 colorimetric assay kit was
from R&D Systems. Hoechst 33342 and antibody to cytochrome c oxidase
(COX) subunit IV (clone 20E8-C12) were from Molecular Probes, Inc.
Antibody to cytochrome c (clone 7H8.2C12), antibody to mouse BCL-2
(clone 3F11), and antibody to human BCL-2 (clone 6C8) were from
PharMingen. Antibodies to caspase-9 were from Santa Cruz Biotechnol-
ogy, Inc. and R&D Systems. Rabbit polyclonal antibody to Akt and phos-
 
phospecific antibody for Akt Serine-473 were from New England Biolabs,
Inc., and a rabbit polyclonal phosphospecific antibody for MAP kinase
threonine-202/tyrosine-204 was from Cell Signaling Technology. Fluores-
cein isothiocyanate–conjugated secondary antibody was from Jackson Im-
munoResearch Laboratories. Antibody to hemagglutinin (12CA5) was a
generous gift from Dr. Jeffery Field (University of Pennsylvania, Philadel-
phia, PA). Antibody to activated caspase-3 was a generous gift from Dr.
Robert Siman (University of Pennsylvania, Philadelphia, PA). All other
reagents were obtained from Sigma-Aldrich.
 
Cell Viability, Internucleosomal DNA Fragmentation, 
and Nuclear Condensation
 
HMN1 cells were washed with serum-free DMEM. LY 294002, PD 98059,
or vehicle was diluted into serum-free DMEM at the indicated concentra-
tions. Cell viability and DNA fragmentation were analyzed as described
previously (Zhou et al., 1998). For C2-ceramide–induced apoptosis,
HMN1 cells were maintained in serum-free DMEM for 24 h before exper-
iments. Staining nuclei with Hoechst 33342 was performed as described
previously (Zhou et al., 1998).
 
Cell Transfection and Generation of Stable Cell Lines
 
HMN1 cells were plated in six-well plates and cotransfected with 0.5 
 
m
 
g of
pREP-4 encoding a hygromycin resistance gene and 4.5 
 
m
 
g of pCMV,
pCMVhBcl-2, pCR3.1, or pCR3.1myr-Akt
 
D
 
4-129 (a constitutively active
Akt containing a consensus myristoylation site and lacking the PH do-
main; Kohn et al., 1996; Zhou et al., 1998). 36 h after transfection, cells
were replated into 10-cm plates and selected in medium containing 350
 
m
 
g/ml hygromycin for 4 wk to select stable clones. Clones expressing hu-
man Bcl-2 were screened with monoclonal antibody, 6C8, for human Bcl-2
(PharMingen). Clones expressing constitutively active Akt were screened
with anti-hemagglutinin (anti–HA) monoclonal antibody (12CA5) and
verified by anti–Akt antibody as well as anti–Akt (Ser473) phosphospe-
cific antibody (New England Biolabs, Inc.).
 
SDS-PAGE and Western Blot Analysis
 
Proteins were separated by SDS-PAGE and transferred onto PVDF
membranes, followed by probing with various antibodies. Bound antibod-
ies were detected using appropriate peroxidase-coupled secondary anti-
bodies, followed by detection using the Enhanced Chemiluminescence
system (NEN Life Science Products).
 
Subcellular Fractionation
 
The cytosolic fraction for detecting cytochrome c was prepared as de-
scribed by Erhardt et al., (1999). In brief, HMN1 cells were harvested by
centrifugation at 600 
 
g
 
 for 5 min at 4
 
8
 
C. The cell pellet was washed once
with ice-cold phosphate-buffered saline and resuspended in 5 vol of buffer
(20 mM Hepes, pH 7.5, 10 mM KCl, 1.5 mM MgCl
 
2
 
, 1 mM sodium EDTA,
1 mM sodium EGTA, 1 mM dithiothreitol, 10 
 
m
 
g/ml leupeptin, 2 
 
m
 
g/ml
aprotinin, and 0.1 mM PMSF) containing 250 mM sucrose. Cells were ho-
mogenized with 20 strokes of a Dounce homogenizer, and the homoge-
nates were centrifuged at 900 
 
g
 
 for 5 min at 4
 
8
 
C to remove nuclei. Super-
natants were centrifuged at 10,000 
 
g
 
 for 15 min at 4
 
8
 
C. The resulting
supernatants were used as the cytosolic fraction for detecting cytochrome
c and the resulting pellets were used as a positive control for mitochon-
drial protein cytochrome c oxidase (COX) subunit IV.
 
Preparation of Cell-free Extracts and
Cell-free Reactions
 
Cell-free extracts were generated from HMN1 cells as described by Slee et
al. (1999) with some modifications. Cells were pelleted and washed twice
with PBS, pH 7.2, followed by washing once with 5 ml of ice-cold cell ex-
tract buffer (CEB; 20 mM Hepes-KOH, pH 7.5, 10 mM KCl, 1.5 mM
MgCl2, 1 mM EDTA, 1 mM EGTA, 1 mM Na
 
3
 
VO
 
4
 
, 1 
 
m
 
M okadaic acid, 1
mM dithiothreitol, 100 
 
m
 
M PMSF, 10 
 
m
 
g/ml leupeptin, 2 
 
m
 
g/ml aprotinin).
The cell pellet was resuspended in 2 vol of ice-cold CEB and incubated on
ice for 15 min. Cells in CEB were then transferred to a 2-ml Dounce ho-
mogenizer and disrupted with 20 strokes of a B-type pestle. Lysates were
transferred to Eppendorf tubes and centrifuged at 15,000 
 
g
 
 for 15 min at
4
 
8
 
C. The resulting supernatants were obtained as postnuclear extracts and
frozen in aliquots at 
 
2
 
80
 
8
 
C until required. Cell-free reactions were set up
in a 120-
 
m
 
l reaction volume. Cell extracts were brought to a final volume
 
1
 
Abbreviations used in this paper:
 
 CEB, cell extract buffer; HA, hemagglu-
tinin; HMN1, hybrid motor neuron 1; MAP, mitogen-activated protein;
PARP, poly (ADP-ribose) polymerase; PI 3-kinase, phosphoinositide 3
kinase. 
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of 120 
 
m
 
l in CEB with protein concentration of 2.5 mg/ml. Apoptosis was
induced by addition of bovine heart cytochrome c and dATP to extracts at
a final concentration of 50 
 
m
 
g/ml and 1 mM, respectively. The reactions
were then incubated at 37
 
8
 
C. At the indicated time points, 20 
 
m
 
l of reac-
tions were removed and boiled with 10 
 
m
 
l 3
 
3
 
 sample buffer for 5 min at
95
 
8
 
C. Samples were frozen at 
 
2
 
20
 
8
 
C for subsequent SDS-PAGE/Western
blot analysis. Addition of cytochrome c and dATP to nonapoptotic
HMN1 cell extracts induces rapid cleavage of poly (ADP-ribose) poly-
merase (PARP) by activated caspase-3. On the other hand, addition of
BSA and dATP does not lead to PARP cleavage (data not shown). These
observations suggest that, in this cell free system, caspase activation is
strictly dependent on the presence of cytochrome c.
 
Colorimetric Caspase-9 Activity Assay
 
Cell extracts were incubated in the presence or absence of cytochrome c
and dATP at 37
 
8
 
C for 15 min as described above. Then the lysates were
incubated with caspase-9 colorimetric substrate (LEHD-pNA) to measure
caspase-9 activity according to the protocol suggested by the manufac-
 
turer. The cleavage of the peptide was quantitated spectrophotometrically
at a wavelength of 405 nm. The results are expressed as fold increase in
caspase-9 activity of apoptotic reactions (cytochrome c and dATP added)
compared with that of control reactions (BSA and dATP added).
 
Immunoprecipitation and Akt Kinase Reaction
 
HMN1 clones expressing constitutively active Akt were lysed in ice-cold ly-
sis buffer (20 mM Tris-HCL, pH 7.4, 10 mM MgCl
 
2
 
, 10 mM NaCl, 1 mM
EGTA, 5 mM Na
 
3
 
VO
 
4
 
, 1 mM dithiothreitol, 1 mM PMSF, 1 
 
m
 
g/ml leupep-
tin, 10 
 
m
 
g/ml aprotinin) as described previously (Zhou et al., 1998). The cell
lysates were then incubated with either monoclonal anti–HA antibody
(12CA5) or control mouse immunoglobulin for 2 h at 4
 
8
 
C. Protein A
sepharose was then added and incubated for another hour. The beads were
then washed three times with cold lysis buffer, and then incubated with 120
 
m
 
l vector lysates (CEB, 20 
 
m
 
M ATP) at 30
 
8
 
C. After 30 min, bovine heart cy-
tochrome c and dATP were added and the reactions were incubated at 37
 
8
 
C.
 
Microinjection
 
Cell microinjection was performed as previously described (Cass et al.,
1999). HMN1 or HMN1/myr-Akt cells were plated on 35-mm plates 24 h
before injection. Rabbit IgG alone or rabbit IgG plus 5 mg/ml cytochrome
c (Sigma-Aldrich; bovine heart cytochrome c, diluted in H
 
2
 
O and freshly
prepared for each experiment) were injected into the cytoplasm. Injected
cells were stained with FITC-conjugated anti–rabbit IgG, and then incu-
bated with Hoechst 33258 (4 
 
m
 
g/ml) for nuclear staining. The intracellular
concentrations of microinjected proteins are estimated to represent a 10–
100-fold dilution of the pipette concentration based on an estimated
HMN1 cell volume of 4–5 pl. We estimate that 0.2–2 pg cytochrome c per
cell is delivered after injection of cytochrome c at 5 mg/ml. At various
times after injection, injected cells were scored for apoptosis based on
condensed chromatin or fragmented nuclei. The percentage of apoptotic
cells was calculated as the number of apoptotic nuclei versus total number
of injected cells. Data represent the mean 
 
6 
 
SEM from three or more in-
dependent experiments.
 
Results
 
PI 3-kinase Is Required for HMN1 Cell Survival 
 
Depending on the type of neuron, either PI 3-kinase or
MAP kinase can promote cell survival (Pettmann and
Henderson, 1998). To determine which pathway (or both
pathways) is required for HMN1 cell survival, HMN1 cells
were treated with the PI 3-kinase inhibitor, LY 294002, or
with the MEK1 inhibitor PD 98059. In HMN1 cells, PD
98059 blocked serum-stimulated ERK phosphorylation at
threonine-202/tyrosine-204, indicating effective inhibition
of MEK1, and LY 294002 blocked serum- and insulin-stim-
ulated Akt phosphorylation at serine-473, indicating effec-
tive inhibition of PI 3-kinase (Fig. 1 A). After 18 h, LY
294002 induced 
 
z
 
50% cell death, whereas PD 98059 had
no obvious effect on cell survival (Fig. 1 B). Consistent with
LY 294002 but not PD 98059–inducing apoptosis in HMN1
cells, DNA laddering was observed only in LY 294002-
treated cells (Fig. 1 C). Other features characteristic of ap-
optosis including cell shrinkage, membrane blebbing, and
chromatin condensation were also present in cells treated
with LY 294002 but not in cells treated with PD 98059
(data not shown), indicating that PI 3-kinase but not MAP
kinase plays an essential role in HMN1 cell survival.
 
Caspase-3 Activation, PARP Cleavage and Cytochrome 
c Release from Mitochondria during C2-Ceramide 
Induced HMN1 Cell Death 
 
A variety of apoptotic stimuli have been shown to gener-
ate ceramide that can serve as a lipid messenger to induce
apoptosis (Hannun, 1996). We previously reported that
Figure 1. Inhibition of PI 3-kinase signaling but not MAPK signal-
ing induces apoptosis of HMN1 cells. (A) PD 98059 inhibits
MAPK signaling (ERK phosphorylation at threonine-202/ty-
rosine-204) and LY 294002 inhibits PI 3-kinase signaling (Akt
phosphorylation at serine-473). HMN1 cells were grown in serum-
free medium for 16 h, followed by stimulation with 10 mg/ml insu-
lin or 20% fetal bovine serum in the absence or presence of 30 mM
PD 98059 or LY 294002. Samples were blotted with antibodies
against phospho-ERK or phospho-Akt. (B) LY 204002, but not
PD98059, induces cell death. HMN1 cells were treated with 30 mM
LY 294002 (dissolved in ethanol) or 30 mM PD 98059 (dissolved in
DMSO), and cell viability was determined after 18 h. 1, DMSO; 2,
PD 98059; 3, ethanol; 4, LY 294002. LY 294002 causes a significant
decrease in viability. Data represent mean 6 SEM of three inde-
pendent experiments. (C) HMN1 cells were treated as described
above, and after 18 h soluble DNA was extracted for DNA frag-
mentation assay. 1, DMSO; 2, PD 98059; 3, ethanol; 4, LY 294002.
Note prominent DNA laddering after treatment with LY 294002.
Data are from a representative experiment performed three times. 
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cell-permeable C2-ceramide induces HMN1 cell death and
inhibits Akt activation that may represent one mecha-
nism by which ceramide promotes apoptosis (Zhou et al.,
1998). However, the cellular events involved in ceramide-
induced apoptosis remain undetermined. Since caspase-3
activation plays a central role in neuronal apoptosis, we
examined caspase-3 activation and cleavage of its sub-
strate, PARP, during ceramide-induced apoptosis. Cells
treated with C2-ceramide, but not with an inactive cer-
amide analogue C2-dihydroceramide exhibited activation
of caspase-3 after 3 h based on processing of procaspase-3
into active caspase-3 and the appearance of the p17 sub-
unit. Caspase-3 activation was inhibited by the broad
caspase inhibitor zVAD-fmk (benzyloxycarbonyl-Val-
Ala-Asp-fluoromethylketone) (Fig. 2 A). Consistent with
the observed caspase-3 activation, PARP, a known sub-
strate for caspase-3, was cleaved with a similar time
course, and zVAD-fmk effectively blocked PARP cleav-
age (Fig. 2 B). Another important cellular event in the
progression of apoptosis is the release of cytochrome c
from mitochondria; therefore, we examined the distribu-
Figure 2. Caspase-3 activation, PARP cleavage and cytochrome
c release from mitochondria during C2-ceramide–induced HMN1
cell death. (A) C2-ceramide induces caspase-3 activation. HMN1
cells were treated with 50 mM C2-ceramide, 50 mM C2-dihydro-
ceramide, or 50 mM C2-ceramide plus 100 mM zVAD-fmk for the
indicated period. The blot was probed with a polyclonal antibody
to caspase-3. Note that zVAD-fmk inhibits caspase-3 processing.
(B) C2-ceramide induces PARP cleavage. HMN1 cells were
treated as described above for the indicated period. The blot was
probed with an mAb to PARP. Note that zVAD-fmk blocks
PARP cleavage. (C) C2-ceramide induces cytochrome c release
into the cytosol. HMN1 cells were treated as described above for
the indicated period. At each time point, cells were fractionated
and equal amounts of cytosolic protein were loaded into each
lane. The blot was probed with an mAb to cytochrome c (top), or
an mAb to a-tubulin (middle). an mAb to cytochrome c oxidase
subunit IV (COX IV) was used to show the cytosolic fraction is
not contaminated with mitochondria (bottom; M represents mi-
tochondria as a positive control for COX IV). Note that zVAD-
fmk does not block cytochrome c release.
Figure 3. Establishing stable HMN1 lines overexpressing consti-
tutively active Akt or human Bcl-2. (A) Detection of endogenous
and transfected Akt in stable HMN1 clones expressing active
Akt. HMN1 cells were transfected with either control vector
(pCR3.1) or myr-AktD4-129 and selected with hygromycin B
(350 mg/ml) for 4 wk. V1 and V2 represent control clones trans-
fected with vector. A7, B10, and C10 represent stable HMN1 cell
lines expressing myr-AktD4-129. Endogenous Akt runs at z60
kD and myr-AktD4-129 runs at z46 kD. The clones were ana-
lyzed using a polyclonal antibody against Akt (A) and an mAb
against the HA epitope tag (not shown). (B) Detection of acti-
vated/phosphorylated Akt in stable HMN1 clones expressing ac-
tive Akt. Blots were probed with a phosphospecific antibody
against Akt phosphorylated on Ser-473. (C) Detection of stable
HMN1 clones expressing human Bcl-2. HMN1 cells were trans-
fected with either control vector (pCMV) or human Bcl-2 and se-
lected with hygromycin B (350 mg/ml) for 4 wk. V1 and V2 repre-
sent control clones transfected with vector. 1, 2, and 9 represent
the stable HMN1 cells expressing human Bcl-2. The clones were
analyzed using an mAb specific for human Bcl-2. 
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tion of cytochrome c in HMN 1 cells treated with C2-cer-
amide. Cell fractionation studies revealed that C2-ceramide
treatment leads to cytochrome c redistribution into the cy-
tosolic fraction, which can be detected as early as 1 h (Fig.
2 C, top). This observation is consistent with the notion
that cytochrome c release occurs before caspase-3 activa-
tion. Interestingly, zVAD-fmk did not block cytochrome c
release from the mitochondria (Fig. 2 C), even though it
inhibited caspase-3 activation and PARP cleavage (Fig. 2,
A and B). These results suggest that cytochrome c release
from mitochondria during ceramide-induced apoptosis in
HMN1 cells is independent of caspase activation.
 
Establishing Stable HMN1 Lines Overexpressing 
Constitutively Active Akt or Human Bcl-2 
 
One mechanism by which active Akt protects BAF/3 cells
from interleukin-3 withdrawal–induced apoptosis is to in-
crease the expression level of Bcl-2 (Ahmed et al., 1997).
We previously showed that transiently overexpressing
constitutively active Akt in HMN1 cells inhibits C2-cer-
amide–induced apoptosis; however, the expression levels
of Bcl-2, Bcl-x, or Bax were not changed (Zhou et al.,
1998; data not shown). The lack of an effect in HMN1 cells
may have been due to the low transfection efficiency in
our transiently transfected cells or possibly that active Akt
may protect neurons from apoptosis via a mechanism dif-
ferent from that in BAF/3 cells. To elucidate the cellu-
lar mechanisms by which Akt inhibits apoptosis, stable
HMN1 lines overexpressing constitutively active Akt were
generated. The expression of constitutively active myr-
Akt
 
D
 
4-129 in these clones was confirmed using anti–Akt
antibody (Fig. 3 A) and antiphosphospecific Akt (Ser473)
antibody (B). Note that myr-Akt
 
D
 
4-129 has a much higher
degree of Ser473 phosphorylation than endogenous Akt
 
Figure 4.
 
Inhibition of apoptosis by constitutively active Akt and
Bcl-2. (A) Fluorescence photomicrographs of Hoechst 33342
staining of HMN1 cells transfected with pCMV, human Bcl-2,
pCR3.1, or myr-Akt
 
D
 
4-129. Cells were treated with 30 
 
m
 
M C2-
ceramide for 5 h. (B) Constitutively active Akt and Bcl-2 inhibit
ceramide-induced HMN1 cell apoptosis. Cells were treated with
30 
 
m
 
M C2-ceramide for 5 h and apoptosis was assayed by Hoechst
33342 staining. Data represent mean 
 
6 
 
SEM for three indepen-
dent experiments. (C) Constitutively active Akt and Bcl-2 inhibit
DNA fragmentation in HMN1 cells. Cells were treated with 30
 
m
 
M C2-ceramide for 0, 3, or 5 h, and soluble DNA was extracted
for DNA fragmentation assay. Data are from a representative ex-
periment performed three times.
Figure 5. Overexpressing
constitutive Akt does not
change Bcl-2, Bcl-x, or Bax
expression  in HMN1 cells.
Equal amounts of cell lysates
from two control vector lines
(V1 and V2) or three active
Akt lines (A7, B10, and C10)
were separated by SDS-
PAGE, followed by Western
blot with an anti–mouse Bcl-2
antibody, an anti–Bcl-x anti-
body, or an anti–Bax anti-
body. For the internal con-
trol, blots were stripped and
reprobed with an mAb spe-
cific for a-tubulin. Data are
from a representative experi-
ment performed three times. 
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despite its relative lower expression level. HMN1 lines
overexpressing human Bcl-2 were also generated to help
dissect the role of Akt in regulating apoptosis (Fig. 3 C).
 
Inhibition of Apoptosis by Constitutively Active Akt 
and Bcl-2
 
Both constitutively active Akt and Bcl-2 significantly pro-
tected HMN1 cells from apoptosis induced by C2-cer-
amide as determined by morphological changes and the
extent of nuclear condensation (Fig. 4 A). When treated
with 30 
 
m
 
M C2-ceramide for 5 h, most cells overexpressing
constitutively active Akt kinase or Bcl-2 remained flat and
exhibited normal nuclear morphology, whereas vector-
transfected cells showed extensive cell shrinkage, mem-
brane blebbing, and nuclear condensation (Fig. 4 A, and
data not shown). Quantitation of apoptosis by counting
Hoechst-stained condensed nuclei revealed that active
Akt and Bcl-2 were approximately equally effective at in-
hibiting apoptosis (Fig. 4 B). This is consistent with data
showing that C2-ceramide induced DNA fragmentation in
the two vector control lines, whereas DNA fragmentation
was inhibited in myr-Akt
 
D
 
4-129 and Bcl-2–expressing sta-
ble cell lines (Fig. 4 C).
 
Overexpressing Constitutively Active Akt Does Not 
Alter Bcl-2, Bcl-x, or Bax Expression Levels 
 
Bcl-2 family proteins play an important role in regulating
apoptosis and a growing number of signaling pathways are
Figure 6. Bcl-2 but not active Akt blocks cytochrome c release. (A) Active Akt fails to inhibit cytochrome c release induced by C2-cer-
amide. Vector control line or two independent active Akt lines were treated with 30 mM C2-ceramide for the indicated period. Cells
were then fractionated and equal amounts of cytosolic protein were loaded into each lane. The blot was probed with an mAb to cyto-
chrome c (top). For the internal control, the blots were stripped and reprobed with antibody to a-tubulin (middle). The cytosolic frac-
tion was confirmed to be without mitochondria with an mAb to COX IV (bottom; M represents mitochondria as a positive control for
COX IV). Data are from a representative experiment performed three times. Note the delay in cytochrome c release is due to cells be-
ing treated with 30 mM C2-ceramide in this experiment rather than 50 mM C2-ceramide as used in experiments shown in Fig. 2 C. (B)
Quantification of cytochrome c release. Bars: white, pCR vector; black, myr-Akt clone A7; stippled, myr-Akt clone B10. Data represent
mean 6 SEM of three independent experiments. (C) Bcl-2 inhibits cytochrome c release induced by C2-ceramide. Vector control line
or two independent Bcl-2 lines were treated with 30 mM C2-ceramide for the indicated period. Cells were then fractionated and equal
amounts of cytosolic protein were loaded into each lane. The blot was probed with an mAb to cytochrome c (top). For the internal con-
trol, the blots were stripped and reprobed with antibody to a-tubulin (middle). The cytosolic fraction was confirmed to be without mito-
chondria with an mAb to COX IV (bottom; M represents mitochondria as a positive control for COX IV). Data are from a representa-
tive experiment performed three times. (D) Quantification of cytochrome c release. Bars: white, pCMV vector; black, hBcl-2 clone 98-1;
stripped, hBcl-2 clone 98-2. Data represent mean 6 SEM of three independent experiments. 
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known to regulate apoptosis by modulating expression of
Bcl-2 family members (Gross et al., 1999). We therefore
explored the possibility that Akt may inhibit apoptosis in
HMN1 cells by regulating the expression levels of three
key members of the Bcl-2 family: Bcl-2, Bcl-x, and Bax.
Western blots of vector-transfected cells and active myr-
Akt
 
D
 
4-129–expressing cells indicated that stable expres-
sion of activated Akt did not alter Bcl-2, Bcl-x, or Bax ex-
pression to inhibit apoptosis (Fig. 5).
 
Bcl-2, but Not Active Akt, Blocks Cytochrome c 
Release 
 
Bad, a proapoptotic member of the Bcl-2 family, has been
identified as one of the downstream targets of Akt. Acti-
vated Akt increases Bad phosphorylation at Ser136, which
shifts binding of Bad from Bcl-XL to 14-3-3 protein (Zha
et al., 1996; Datta et al., 1997). Based on this observation,
it has been proposed that Akt inhibits apoptosis mainly
Figure 7. Active Akt but not Bcl-2 inhibits caspase activation induced by cytochrome c in a cell-free system. (A) Extracts from active
Akt stable cell lines but not a vector control line inhibit cytochrome c–induced PARP cleavage. Cell-free assays were prepared as de-
scribed in Materials and Methods and samples were taken at the indicated time. The blot was probed with an mAb against PARP. Note
that the addition of cytochrome c induced rapid cleavage of intact PARP (116 kD) into the 85-kD fragment, whereas addition of BSA
did not. PARP cleavage was markedly inhibited in lysates from two active Akt clones (A7, middle, and B10, bottom) compared with
vector control (top). (B) Extracts from Bcl-2 stable cell lines do not inhibit cytochrome c–induced PARP cleavage. Cell-free assays
were performed as described above for the indicated period. The blot was probed with an mAb against PARP. Note that addition of
cytochrome c induced a similar degree of PARP cleavage in both vector control cells (top) and two Bcl-2 stable lines (98-1, middle, and
98-2, bottom). (C) Extracts from active Akt stable cell lines but not a vector control line inhibit cytochrome c–induced caspase-3 cleav-
age. Cell-free assays were performed as described above. The blots were probed with a polyclonal antibody selectively recognizing
cleaved/activated caspase-3. Note that caspase-3 cleavage/activation was markedly inhibited in two active Akt clones (middle and bot-
tom) compared with vector control (top). Cleaved products represent the 20- and 17-kD processed caspase-3. (D) Caspase-9 activity
induced by cytochrome c is inhibited in cell extracts from two active Akt clones compared with vector control. Data represent mean 6
SEM of three independent experiments. *P , 0.01 by Student’s t test.The Journal of Cell Biology, Volume 151, 2000 490
through maintaining the prosurvival function of Bcl-XL,
which regulates cytochrome c release from mitochondria.
We tested this model by examining whether active Akt
can inhibit cytochrome c redistribution in C2-ceramide in-
duced apoptosis. Surprisingly, Akt did not block cyto-
chrome c release into the cytosol (Fig. 6, A and B),
whereas Bcl-2 suppressed cytochrome c release (C and D).
This observation is in agreement with the well established
role for Bcl-2 to inhibit apoptosis by blocking cytochrome
c release from mitochondria (Kluck et al., 1997; Yang et
al., 1997). Moreover, it suggests that active Akt inhibits
apoptosis at a step after release of cytochrome c into the
cytoplasm.
Akt, but Not Bcl-2, Inhibits Caspase Activation 
Induced by Cytochrome c in a Cell-free System 
To confirm that expressing active Akt inhibits the apop-
totic cascade downstream of cytochrome c release, a cell-
free system was used to examine PARP cleavage and
caspase-3 activation. In extracts prepared from vector-
transfected cells, PARP was rapidly cleaved. After a 15-
min incubation with cytochrome c and dATP, only a small
fraction of intact PARP remained and, by 30 min, all intact
PARP disappeared (Fig. 7 A). In contrast, in extracts pre-
pared from Akt stable cell lines, cytochrome c–induced
PARP cleavage was markedly inhibited and delayed. The
cleaved PARP fragment was detectable only after 60–90
min and a large percentage of intact PARP was still
present after 120 min (Fig. 7 A). These data confirm that
active Akt inhibits caspase activation downstream of cyto-
chrome c. On the other hand, PARP cleavage induced by
cytochrome c in extracts prepared from Bcl-2–stable lines
proceeded similarly to cleavage in vector-control cell ex-
tracts (Fig. 7 B). Taken together, these cell-free studies
suggest that Akt can regulate apoptosis at a postmitochon-
drial level, whereas Bcl-2 regulates apoptosis primarily at
the mitochondrial level. Using an antibody that recognizes
cleaved/activated caspase-3, we further analyzed caspase-3
processing induced by cytochrome c in the cell-free assay.
Consistent with results for PARP cleavage, caspase-3
cleavage/activation was also inhibited in extracts prepared
from Akt-stable lines compared with caspase-3 cleavage/
activation in vector-control cell extracts (Fig. 7 C). Since
caspase-9 is the initiator caspase for cleaving and activat-
ing caspase-3, we examined whether caspase-9 activation
by cytochrome c and dATP was inhibited in extracts pre-
pared from Akt-stable lines (Fig. 7 D). Caspase-9 activity
assays showed that activation of caspase-9 by cytochrome
Figure 8. Overexpressing constitutively active Akt suppresses
apoptosis after microinjection of cytochrome c. (A) Fluorescent
photomicrographs of FITC-labeled injected cells (left) and
Hoechst 33342 nuclear staining (right). Note that cytochrome c
but not rabbit IgG induces chromatin condensation in injected
cells. Both zVAD pretreatment and expressing active Akt pre-
vented cytochrome c–induced chromatin condensation in in-
jected cells. (B) Quantification of the protective effects of Akt on
inhibiting cytochrome c–induced apoptosis. Cells were injected
with cytochrome c and, after 1, 2, or 3 h, apoptosis of injected
cells was analyzed as described in Materials and Methods. Data
represent the mean 6 SEM from three or more independent ex-
periments.Zhou et al. Akt Inhibits Apoptosis after Cytochrome c Release 491
c and dATP was inhibited in extracts prepared from Akt-
stable lines compared with those in vector-control cell
extracts, indicating that expressing active Akt effectively
inhibits the cytochrome c–initiated caspase activation
cascade.
Constitutively Active Akt Inhibits Apoptosis After 
Microinjection of Cytochrome c
To determine whether Akt inhibits cytochrome c–induced
apoptosis in vivo, purified cytochrome c was microinjected
into the cytoplasm of Akt-expressing and vector-trans-
fected cells. Control injections did not induce apoptosis,
whereas microinjection of cytochrome c was sufficient to
induce rapid apoptosis in HMN1 cells. Cytochrome c but
not control-injected cells exhibited condensed and/or frag-
mented nuclei (Fig. 8 A). Moreover, constitutively active
Akt inhibited and delayed cytochrome c–induced apopto-
sis (Fig. 8 B), which is consistent with results obtained
from the cell-free system in which expressing active Akt-
inhibited apoptotic events such as PARP cleavage and ac-
tivation of caspase-9 and caspase-3 in response to cyto-
chrome c (Fig. 7, A, C, and D).
Immunoprecipitated Active Akt Added to Vector Cell 
Extracts Inhibits Caspase Activation Induced by 
Cytochrome c 
To test the role of posttranslational modification of pro-
teins by active Akt in inhibiting cytochrome c–induced
caspase activation, active Akt was immunoprecipitated
from cells expressing active Akt and incubated with vector
cell extracts. Subsequently, cytochrome c and dATP were
added to initiate caspase activation. PARP cleavage was
markedly inhibited and delayed in vector-cell extracts pre-
incubated with active Akt (Fig. 9). In contrast, PARP
cleavage was not altered in vector cell extracts preincu-
bated with control mouse immunoglobulin immunoprecip-
itate (Fig. 9). These results indicate that active Akt has a
direct effect on inhibiting cytochrome c–induced caspase
activation, and suggest that the inhibition by Akt is
through posttranslational modification of cytosolic fac-
tor(s) involved in activating caspases.
Discussion
Apoptotic death of neurons occurs at many different de-
velopmental stages. The most frequently studied and mod-
eled neuronal death is that occurring during the period
of synaptogenesis (Oppenheim, 1991). Neurons are pro-
duced in excess, and then compete for specific neu-
rotrophic factors produced by their target neurons or or-
gans. Neurons that do not get sufficient neurotrophic
factor die; this appears to be important for matching the
extent of innervation with the size of the target field. Com-
pelling evidence supporting this hypothesis comes from a
number of studies showing that neurotrophic factors regu-
late target-dependent apoptotic neuronal death during de-
velopment in vivo and in vitro (Snider, 1994). The two ma-
jor pathways implicated in supporting neuronal survival by
neurotrophic factors are the PI 3-kinase and MAP kinase
pathways (Pettmann and Henderson, 1998).
Activation of PI 3-kinase generates the lipid products
phosphatidylinositol 3,4-biphosphate (PIP2) and phos-
phatidylinositol 3,4,5-triphosphate (PIP3). These products
subsequently activate Akt, a serine-threonine protein ki-
nase believed to be the major effector for PI 3-kinase to
promote cell survival (Franke et al., 1997). Pharmacologi-
cal studies with PI 3-kinase and/or MEK inhibitors indi-
cate that only the PI 3-kinase pathway is essential for
HMN1 cell survival (Fig. 1). We previously showed that
C2-ceramide inhibited insulin-stimulated Akt activation
but did not affect the activity of a membrane-targeted,
constitutively active form of Akt, indicating that mem-
brane association activates Akt and bypasses the inhibi-
tory effect of ceramide (Zhou et al., 1998). In this study,
we generated stable HMN1 cell lines expressing constitu-
tively active Akt to explore the cellular mechanisms
through which Akt regulates cell survival. Overexpression
of active Akt inhibits apoptosis, as exemplified by its in-
hibitory effects on caspase-3 activation, PARP cleavage,
and DNA fragmentation. However, unlike the observa-
tion that Akt upregulates Bcl-2 expression in BAF/3 cells
(Ahmed et al., 1997), Akt promotes HMN1 cell survival in
the absence of altering Bcl-2, Bcl-X, and Bax expression,
which is consistent with data from hippocampal H19-7
neuronal cells and epithelial BRK cells (Eves et al., 1998;
Sabbatini and McCormick, 1999). Nevertheless, given the
pivotal role of BCL-2 family proteins in regulating apopto-
sis and a growing number of signaling pathways shown to
regulate apoptosis by modulating expression of BCL-2
family members (Gross et al., 1999), these results do not
rule out the possibility that Akt may regulate the expres-
sion of other members of the BCL-2 family to inhibit apop-
tosis.
Apoptosis induced by a variety of initiators such as acti-
vation of p75 low affinity NGF receptor and growth factor
withdrawal is associated with increased ceramide produc-
tion. In addition, a strong correlation exists between pro-
duction of ceramide and subsequent cell death (Hannun,
1996; Mathias et al., 1998). Moreover, cell-permeable cer-
Figure 9. Addition of active Akt to vector cell extracts inhibits
cytochrome c–induced PARP cleavage in a cell-free assay. Cell
extracts from the vector line were incubated with either control
mouse immunoglobulin immunoprecipitation (2 myr-Akt) or
immunoprecipitated active Akt [1 myr-Akt (A7) or (B10)] from
either the A7 or B10 line that expresses constitutively active Akt.
Cytochrome c and dATP were then added to initiate caspase ac-
tivation and PARP cleavage. Data are from a representative ex-
periment performed three times.The Journal of Cell Biology, Volume 151, 2000 492
amide analogues induce apoptosis in many different cell
types including neurons (Hannun, 1996; Mathias et al.,
1998). These observations are consistent with ceramide
acting as a lipid second messenger that functions to link
cell-surface receptors and environmental stresses to the
cellular apoptotic machinery. However, the cellular mech-
anisms for ceramide-induced apoptosis remain unclear.
Our current study as well as work by others suggests that
caspase activation is required for ceramide-induced ap-
optosis and that ceramide-induced apoptosis can be
suppressed by either constitutively active Akt or Bcl-2,
probably by different cellular mechanisms. Embryonic fibro-
blasts lacking Apaf-1 are less susceptible to C6-ceramide–
induced apoptosis than wide-type embryonic fibroblasts,
suggesting that Apaf-1 is involved in ceramide-induced ap-
optosis (Cecconi et al., 1998). Further studies are needed
to determine whether members of the Bcl-2 family, such as
Bax are involved in ceramide-induced apoptosis.
Cytochrome c release from mitochondria represents an
important control point during apoptosis, although the
mechanisms causing cytochrome c release remain unclear
(Green and Reed, 1998). It has been proposed that at least
two different mechanisms exist for cytochrome c release
from mitochondria, one that is caspase dependent and the
other that is caspase independent. In Fas-induced apopto-
sis, oligomerization of the Fas receptor leads to recruit-
ment of FADD and subsequent caspase-8 activation (Na-
gata, 1997). Activated caspase-8 cleaves BID, a BH3
domain-only proapoptotic member of the BCL-2 family.
The cleaved p15 BID fragment translocates to mitochon-
dria, where it causes release of cytochrome c, probably by
changing the conformation of Bax (Li et al., 1998; Luo et
al., 1998; Desagher et al., 1999). Bid-deficient hepatocytes
do not release cytochrome c in response to agonistic anti–
Fas antibody, which confirms the importance for cleaved
Bid to induce cytochrome c release in this model (Yin et
al., 1999). In our study, C2-ceramide–induced cytochrome
c release appears to be caspase independent since a broad
caspase inhibitor, zVAD-fmk, inhibits caspase activation
but not cytochrome c translocation. The mechanism for
caspase-independent release of cytochrome c remains un-
clear. A recent study (Kennedy et al., 1999) indicates that
Akt inhibits the release of cytochrome c from mitochon-
dria after UV irradiation, which may involve activation
of cell-surface Fas receptor (Rehemtulla et al., 1997;
Aragane et al., 1998). In contrast, our data indicate that
Akt fails to inhibit cytochrome c release induced by cer-
amide via a caspase-independent mechanism. Therefore,
the function for Akt to regulate cytochrome c release may
vary in response to different apoptotic stimuli or within a
different cellular context.
In mammalian cells, the release of cytochrome c from mi-
tochondria has been proposed as the critical event for cells
to initiate the apoptotic cascade. In the cytosol, cytochrome
c binds to Apaf-1 and triggers Apaf-1–mediated caspase-9
activation. Activated caspase-9 propagates the death signal
by activating caspase-3 and other caspases (Slee et al., 1999;
Zou et al., 1999). In cell-free assays of apoptosis, exoge-
nously added cytochrome c initiates rapid apoptotic events,
including caspase-3 activation and DNA fragmentation
(Liu et al., 1996; Li et al., 1997a; Slee et al., 1999). Data
from our cell fractionation study and cell-free assay are
consistent with Bcl-2 acting to inhibit apoptosis mainly at
the mitochondrial level to suppress cytochrome c release,
since Bcl-2 inhibits the release of cytochrome c but fails to
inhibit caspase activation induced by added cytochrome c
in the cell-free assay. Akt phosphorylates and inactivates
BAD, which may maintain Bcl-2 and Bcl-xL function, and
it has been suggested that Akt inhibits cell death by pre-
venting cytochrome c release from mitochondria (Kennedy
et al., 1999). In contrast, our data indicate that Akt protects
neural cells from apoptosis at a postmitochondrial stage to
inhibit caspase activation. First, active Akt protects cells
from apoptosis without blocking cytochrome c release into
the cytosol. Second, addition of cytochrome c failed to in-
duce caspase-9 activation, caspase-3 processing, or PARP
cleavage in extracts from cells expressing active Akt. Third,
addition of active Akt to lysates from control cells blocked
cytochrome c–induced caspase activation. Fourth, cells ex-
pressing active Akt are resistant to apoptosis induced by
microinjection of cytochrome c.
Microinjection of purified cytochrome c into the cyto-
plasm induces apoptosis in a variety of cell types, whereas
microinjection of anti–cytochrome c antibody into sympa-
thetic neurons inhibits NGF withdrawal-induced apopto-
sis, indicating that cytochrome c is both sufficient and nec-
essary for apoptosis to progress in vivo (Li et al., 1997b;
Duckett et al., 1998; Neame et al., 1998; Zhivotovsky et al.,
1998). However, recent studies show that certain cell
types, including neurons, have postmitochondrial mecha-
nisms to inhibit the cell death machinery after cytochrome
c release, suggesting a more complicated mechanism for
regulating apoptosis than previously thought (for review,
see Newmeyer and Green, 1998; Reed and Paternostro,
1999). For example, cytochrome c release induced by NGF
withdrawal in sympathetic neurons is a reversible event,
indicating that redistribution of cytochrome c into the cy-
tosol does not always result in irreversible cell death in
neurons (Martinou et al., 1999). Also, microinjection of
cytochrome c into sympathetic neurons is not lethal in the
presence of NGF. Therefore, NGF signaling appears to
block cytochrome c–induced apoptosis in sympathetic
neurons. Sympathetic neurons only commit to apoptosis in
response to cytochrome c after NGF is removed for a pro-
longed period. It is proposed that neurons must undergo
an unidentified event to develop “competence to die” in
addition to the presence of cytochrome c (Deshmukh and
Johnson, 1998). Our data demonstrate that expressing ac-
tive Akt inhibits cytochrome c–induced caspase activation
in a cell-free assay and also suppresses apoptosis after cy-
toplasmic injection of cytochrome c, indicating that Akt
blocks apoptosis in the presence of cytochrome c. In this
regard, loss of Akt signaling may be related to developing
neuronal “competence-to-die” in response to cytochrome
c since prolonged NGF withdrawal may progressively de-
crease PI 3-kinase/ Akt activity and lower the threshold
for cytochrome c to initiate caspase activation.
Recently, cytochrome c was implicated in the pathogene-
sis of Parkinson’s disease since purified cytochrome c stim-
ulates a-synuclein aggregation in vitro and cytochrome c
colocalizes with a-synuclein in Lewy bodies of patients with
Parkinson’s disease (Hashimoto et al., 1999). Our findings
here indicate that Akt protects neural cells from acute apop-
tosis caused by cytochrome c release and may allow cyto-Zhou et al. Akt Inhibits Apoptosis after Cytochrome c Release 493
solic cytochrome c to participate in other cellular process
such as a-synuclein aggregation. Interestingly, expressing
active Akt or treatment with zVAD-fmk inhibited chroma-
tin condensation after cytochrome c injection, yet many
rescued cells still shrank, suggesting that cytochrome c may
cause cell shrinkage independent of caspase activation. It
should be possible to examine additional roles of cyto-
chrome c independent of its effects on apopsome complex
formation in Apaf-1 or caspase-9–deficient neurons.
A growing number of downstream targets of Akt have
been identified, including glycogen synthase kinase-3,
BAD, human caspase-9, and transcription factors such as
CREB, Forkhead, and NFkB (Pap and Cooper, 1998;
Khwaja, 1999). While each of these has been implicated as
an important target for Akt to inhibit apoptosis, in the
present case, caspase-9 appears to be the most likely can-
didate since Akt phosphorylates human caspase-9 and in-
hibits its activity (Cardone et al., 1998), which would pro-
vide a potential mechanism for Akt to inhibit caspase
activation at a postmitochondrial level. However, [32P]or-
thophosphate labeling of cells expressing active Akt indi-
cated that mouse caspase-9 is not phosphorylated by Akt
(data not shown). This may be explained by recent reports
that the consensus Akt phosphorylation sites on human
caspase-9 are not conserved in caspase-9 from other spe-
cies such as mouse caspase-9 in HMN1 cells (Fujita et al.,
1999; Rodriguez et al., 2000). On the other hand, our data
also suggest that there exists an additional, more general
mechanism by which Akt can suppress activation of
caspases by cytochrome c at a postmitochondrial stage.
When added into vector-cell extracts, immunoisolated ac-
tive Akt is sufficient to inhibit caspase activation induced
by cytochrome c, suggesting that active Akt has a direct ef-
fect on inhibiting cytochrome c–induced caspase activa-
tion. One such direct target for Akt may be Apaf-1, which
forms a holoenzyme with caspase-9 and regulates caspase-9
activity (Rodriguez and Lazebnik, 1999). Akt phosphory-
lates Apaf-1 in vitro (our unpublished observations);
however, further studies are needed to determine whether
cellular Apaf-1 is a direct target of Akt, and how the phos-
phorylation status of Apaf-1 may regulate caspase-9 acti-
vation.
In conclusion, our data based on subcellular fraction-
ation, cell-free assays of apoptosis, and microinjection
studies indicate that Akt inhibits apoptosis downstream of
cytochrome c release and before activation of caspase-9
(Fig. 10). The ability of Akt to regulate apoptosis at a post-
mitochondrial stage provides a potential molecular mech-
anism allowing postmitotic cells like neurons to tolerate
leakage of cytochrome c into the cytoplasm when growth
factors are present. A key to understanding postmitochon-
drial regulation of apoptosis by Akt will be future studies
to identify the cellular target(s) of Akt.
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